Lee, Huijin
Park, Chan Soon
Kim, Bongseong
Rhee, Tae-Min
Lee, Heesun
Kim, Yong-Jin
Han, Kyungdo
Kim, Hyung-Kwan https://orcid.org/0000-0001-7950-2131
Funding for this research was provided by:
Boryung Pharmaceutical Co., Ltd. (This project was an investigator-initiated trial. This research was funded by a grant from Boryung Pharmaceutical Co., Ltd. (Seoul, Korea). The funder had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to submit the manuscript.)
Article History
Received: 31 January 2024
Accepted: 13 September 2024
First Online: 1 October 2024
Declarations
:
: This study adhered to the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Seoul National University Hospital (E-2103-004-120), which waived the need for informed consent due to the use of de-identified data.
: Not applicable.
: Hyung-Kwan Kim has received research grants from HK Inno. N, Johnson and Johnson, GSK, Samjin Pharm, ChongKunDang Pharm, Boryung Pharm, and JW Pharm. The authors declare no conflict of interest.